Stent :: Swedish registry results of drug-eluting stents

Boston Scientific Corporation (NYSE: BSX) today commented on results from a Swedish registry assessing the long-term outcomes of drug-eluting stents (DES) versus bare- metal stents (BMS) that were released online today and are scheduled for publication in the March 8th edition of the New England Journal of Medicine.

Ventracor continues to build momentum

Ventracor (ASX: VCR) today reported growing momentum in its European BRACE Study (Better Results And Cost Effectiveness) of the VentrAssist, building on the achievement of major milestones in December_2006.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack